Mental retardation

KRA_PSY_MENTALRET

mental retardation: ['Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual is mentally retarded. IQ scores between 70 and 79 are in the borderline mentally retarded range. Scores below 67 are in the retarded range. (Joynt, Clinical Neurology, 1992, Ch55, p28)']

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F70-F79 Hospital discharge: ICD-9 — 31[7-9] Hospital discharge: ICD-8 — 31[1-5] Cause of death: ICD-10 — F70-F79 Cause of death: ICD-9 — 31[7-9] Cause of death: ICD-8 — 31[1-5] 2 out of 7 registries used, show all original rules.	1540
4. Check minimum number of events None	1540
5. Include endpoints None	1540
6. Filter based on genotype QC (FinnGen only)	1540

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_MENTALRET
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F7
HD_ICD_9	31[7-9]
HD_ICD_8	31[1-5]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F7
COD_ICD_9	31[7-9]
COD_ICD_8	31[1-5]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mental retardation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1540	755	785
Unadjusted period prevalence (%)	0.30	0.26	0.35
Median age at first event (years)	22.22	24.26	20.26

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1433: Matched controls
14304

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

3623.6

323.0

512

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

+∞

286.1

265

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

632.2

271.8

261

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

1342.8

239.4

227

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

11.1

207.7

433

537

N03AG01

ATC

valproic acid; systemic, rectal

12.1

201.8

399

443

N05AX08

ATC

risperidone; systemic

11.0

201.2

420

519

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

308.2

188.7

188

P85

ICPC

Mental retardation

269.1

166.1

167

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

10.6

159.1

333

397

F83

ICD-10 Finland

Mixed specific developmental disorders

20.8

158.4

242

138

N05AH03

ATC

olanzapine; systemic

9.3

144.1

325

437

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

7.4

141.2

377

660

N05BA01

ATC

diazepam; systemic, rectal

6.2

126.5

390

817

N05AA02

ATC

levomepromazine; systemic

12.1

125.1

240

234

G40.9

ICD-10 Finland

Epilepsy, unspecified

13.8

121.3

218

184

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

+∞

115.1

109

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

1163.4

112.0

108

3170A

ICD-9 Finland

Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]

+∞

110.8

105

N05AC02

ATC

thioridazine; oral

21.0

101.3

153

F20.9

ICD-10 Finland

Schizophrenia, unspecified

15.8

100.0

168

119

N04AA02

ATC

biperiden; systemic

19.6

91.4

141

183

Kela drug reimbursment

Lamotrigin and topiramate

24.9

89.7

128

F29

ICD-10 Finland

Unspecified nonorganic psychosis

7.8

87.7

216

319

N05AH04

ATC

quetiapine; oral

3.8

83.1

424

1418

N05BA09

ATC

clobazam; oral

22.8

81.9

120

N05AF03

ATC

chlorprothixene; systemic

12.4

80.8

151

135

N03AF01

ATC

carbamazepine; oral, rectal

9.6

80.1

171

198

N05AD01

ATC

haloperidol; systemic

14.4

79.3

138

105

N05AH02

ATC

clozapine; systemic

12.6

77.8

144

126

F70

ICD-10 Finland

Mild mental retardation

+∞

76.7

A06AD11

ATC

lactulose; oral

5.0

76.5

276

657

R62.0

ICD-10 Finland

Delayed milestone

10.6

76.4

154

160

N05BA06

ATC

lorazepam; systemic, sublingual

8.5

76.2

175

229

31199

ICD-8 Finland

Mild mental retardation, Other and unspecified

+∞

74.6

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

12.6

74.2

137

119

N05AX12

ATC

aripiprazole; systemic

7.1

72.5

188

296

N03AX09

ATC

lamotrigine; oral

6.6

72.2

198

337

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

16.2

70.9

117

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

11.1

69.7

137

135

N05AB03

ATC

perphenazine; systemic, rectal

8.7

69.3

157

200

F71.1

ICD-10 Finland

Moderate mental retardation, significant impairment of behaviour requiring attention or treatment

+∞

69.3

F79.1

ICD-10 Finland

Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment

+∞

69.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.3

66.8

402

1492

N03AX14

ATC

levetiracetam; systemic

9.5

66.1

141

162

P72

ICPC

Schizophrenia

13.9

65.5

115

3170B

ICD-9 Finland

Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,JOSSA KÄYTÄYTYM.HÄIRI]

+∞

64.0

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

45.7

60.4

A28

ICPC

Limited function/disability NOS

4.3

59.4

245

656

31099

ICD-8 Finland

Borderline mental retardation, Other and unspecified

600.8

59.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.8

58.1

210

492

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.9

57.7

203

462

N03AF02

ATC

oxcarbazepine; oral

7.0

57.5

149

232

N03AX11

ATC

topiramate; oral

9.2

55.9

121

142

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

+∞

55.5

N03AG04

ATC

vigabatrin; oral

65.7

54.7

N05CD08

ATC

midazolam; nasal, systemic

8.7

54.6

122

151

3199A

ICD-9 Finland

Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]

+∞

54.5

F78.0

ICD-10 Finland

Other mental retardation, with the statement of no, or minimal, impairment of behaviour

+∞

53.4

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

11.6

53.0

101

EBA15

NOMESCO Finland

Extraction of large number of teeth

7.1

52.6

135

207

XA800

NOMESCO Finland

Neuropsychological investigation

5.0

52.0

180

401

N05CD07

ATC

temazepam; oral

4.3

49.2

201

528

N05AF05

ATC

zuclopenthixol; systemic

16.1

47.5

N06AB04

ATC

citalopram; systemic

2.9

46.9

345

1425

31599

ICD-8 Finland

Unspecified mental retardation, Other and unspecified

+∞

46.0

181

Kela drug reimbursment

Retigabine and vigabatrin

67.2

45.4

SPAT1234

SPAT

Support of social functional capacity

7.0

45.4

117

180

P99

ICPC

Psychological disorders other

6.9

44.7

116

180

N05BA04

ATC

oxazepam; oral

2.7

44.5

379

1702

Z2446

NOMESCO Finland

Social worker

3.3

44.0

249

855

F71.9

ICD-10 Finland

Moderate mental retardation, without mention of impairment of behaviour

+∞

43.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.7

43.6

213

652

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

42.1

219

704

SPAT1229

SPAT

Assessment of need for aid

5.0

41.4

140

302

EBA00

NOMESCO Finland

Extraction of tooth

2.2

41.3

594

3465

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

14.8

40.2

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.3

40.0

221

742

F79

ICD-10 Finland

Unspecified mental retardation

397.2

39.2

G40.89

ICD-10 Finland

Other epilepsy

32.9

39.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.2

38.8

156

401

K03.66

ICD-10 Finland

Tooth plaque

3.4

38.7

212

704

OAB43

SPAT

0.1

38.6

1529

N05AA01

ATC

chlorpromazine; systemic, rectal

12.9

38.0

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.9

37.3

258

1008

Z31.5

ICD-10 Finland

Genetic counselling

4.0

36.9

158

429

V628A

ICD-9 Finland

Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified

194.6

36.9

SPAT1301

SPAT

No procedures

2.2

36.7

492

2741

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

8.3

36.1

104

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.7

36.0

283

1196

188

Kela drug reimbursment

Psychosis requiring demanding treatment

16.9

35.7

A10BA02

ATC

metformin; oral

2.5

35.6

319

1449

L28

ICPC

Limited function/disability (L)

3.2

35.6

211

743

78159

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD

60.1

35.3

SPAT1262

SPAT

Handing over of treatment supplies

2.7

35.1

269

1118

R11

ICD-10 Finland

Nausea and vomiting

3.4

34.8

187

612

RL140

NOMESCO Finland

14.2

34.5

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

34.3

318

1469

Z2445

NOMESCO Finland

Psychologist

3.4

33.9

175

555

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.7

32.9

259

1089

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

12.5

32.1

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.9

32.1

216

825

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

11.5

31.9

C03CA01

ATC

furosemide; systemic

2.5

31.7

276

1227

N03AE01

ATC

clonazepam; systemic

4.3

31.4

121

297

RT150

NOMESCO Finland

12.9

31.4

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

31.2

252

1072

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.8

30.4

223

895

U04

ICPC

Incontinence urine

6.5

30.3

131

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.1

29.5

120

310

P29

ICPC

Psychological sympt/compl other

3.4

29.4

152

481

F73.0

ICD-10 Finland

Profound mental retardation, with the statement of no, or minimal, impairment of behaviour

+∞

29.2

7834D

ICD-9 Finland

Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]

297.1

28.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

28.6

185

685

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

16.3

28.6

F20.5

ICD-10 Finland

Residual schizophrenia

22.1

28.3

T90

ICPC

Diabetes non-insulin dependent

2.5

28.1

259

1180

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

5.1

28.0

187

SDA02

NOMESCO Finland

Parodonthologic therapy

2.0

27.8

504

3101

M03BX02

ATC

tizanidine; oral

0.5

27.7

337

5413

N05AD03

ATC

melperone; systemic

12.3

27.6

H13

ICPC

Plugged feeling ear

2.5

27.5

236

1036

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

27.3

314

1595

31109

ICD-8 Finland

Mild mental retardation, Following infections and intoxications, Unspecified

+∞

27.1

G03DC03

ATC

lynestrenol; oral

7.1

27.0

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

11.7

27.0

F61.0

ICD-10 Finland

Mixed personality disorders

7.4

27.0

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

26.9

176

657

30180

ICD-8 Finland

Personality disorders, Immatura

25.2

26.6

N05AN01

ATC

lithium; oral

6.3

26.5

119

P28

ICPC

Limited function/disability (P)

12.7

26.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

26.1

171

638

F84.0

ICD-10 Finland

Childhood autism

31.6

26.0

RT490

NOMESCO Finland

24.5

25.7

34599

ICD-8 Finland

Epilepsy, Other and unspecified

22.3

25.7

H50.30

ICD-10 Finland

Intermittent esotropy

10.1

25.6

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.2

24.5

292

1499

H50.31

ICD-10 Finland

Intermittent exotropia

7.5

24.3

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

49.2

24.3

M41.4

ICD-10 Finland

Neuromuscular scoliosis

49.2

24.3

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

13.5

24.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

24.0

143

500

N88

ICPC

Epilepsy

11.9

24.0

N03AF03

ATC

rufinamide; oral

+∞

24.0

31100

ICD-8 Finland

Mild mental retardation, Following infections and intoxications, Post infectionem praenatalem

+∞

24.0

N05AC01

ATC

periciazine; systemic

25.9

24.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.3

23.8

129

422

SPAT1254

SPAT

Administration of medicine

2.2

23.8

268

1338

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

23.7

185

765

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.9

23.7

102

278

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.6

23.6

110

320

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.3

23.5

1855

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

23.4

168

662

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

23.4

274

1392

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

23.3

670

4743

WYA20

NOMESCO Finland

Home visit

9.3

23.1

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

25.1

23.1

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

13.8

22.8

H52.2

ICD-10 Finland

Astigmatism

5.2

22.8

144

SPAT1365

SPAT

Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools

11.6

22.7

F20

ICD-10 Finland

Schizophrenia

14.4

22.6

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.6

22.6

181

757

G40.10

ICD-10 Finland

Simple partial seizures

12.0

22.5

K59.09

ICD-10 Finland

Constipation, unspecified

3.4

22.5

113

349

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

32.8

22.4

R1260

NOMESCO Finland

Evaluation of communicative skills

7.3

22.4

29599

ICD-8 Finland

Schizophrenia, Unspecified type

17.0

22.3

F22.0

ICD-10 Finland

Delusional disorder

8.2

22.3

N03AX15

ATC

zonisamide; oral

19.8

22.2

K59.0

ICD-10 Finland

Constipation

3.6

22.1

102

295

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

22.0

131

457

N03AX18

ATC

lacosamide; systemic

11.4

22.0

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.5

21.9

125

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

21.9

209

962

3153A

ICD-9 Finland

Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]

29.5

21.9

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.3

21.4

1528

RS222

NOMESCO Finland

6.5

21.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

21.4

388

2342

A46

ICD-10 Finland

Erysipelas

2.6

21.2

162

661

N06AB06

ATC

sertraline; oral

2.5

21.2

184

804

TJD20

NOMESCO Finland

Change of gastrostomy tube

11.1

21.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

21.1

532

3578

AA1AD

NOMESCO Finland

CT of head and brain

2.1

21.1

258

1332

3153X

ICD-9 Finland

Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]

28.5

21.0

F72.1

ICD-10 Finland

Severe mental retardation, significant impairment of behaviour requiring attention or treatment

+∞

20.9

SPAT1263

SPAT

Sampling

1.7

20.8

593

4136

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.1

20.8

133

29999

ICD-8 Finland

Unspecified psychosis

37.7

20.8

N03AB02

ATC

phenytoin; systemic

11.1

20.7

31009

ICD-8 Finland

Borderline mental retardation, Following infections and intoxications, Unspecified

212.5

20.6

F71

ICD-10 Finland

Moderate mental retardation

212.5

20.6

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

42.2

20.5

G41.9

ICD-10 Finland

Status epilepticus, unspecified

18.6

20.4

RL130

NOMESCO Finland

9.5

20.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

20.1

220

1078

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.4

20.1

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

8.1

20.0

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

20.0

239

R60.0

ICD-10 Finland

Localized oedema

2.9

20.0

129

475

L17

ICPC

Foot/toe symptom/complaint

1.9

20.0

355

2116

N06AB03

ATC

fluoxetine; oral

2.3

20.0

194

898

M01AH05

ATC

etoricoxib; oral

0.6

20.0

330

4995

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

19.9

217

1062

F78.1

ICD-10 Finland

Other mental retardation, significant impairment of behaviour requiring attention or treatment

+∞

19.8

31299

ICD-8 Finland

Moderate mental retardation, Other and unspecified

+∞

19.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

19.7

1003

8225

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009466) Valproate [Moles/volume] in Serum or Plasma

289

221

15.85

312.74

6.1

5.2

umol/l

416.1

372.9

3.47

272

203

(3026008) Bacteria identified in Urine by Culture

554

2768

2.56

63.38

4.2

2.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

13.27

51.24

3.4

3.2

umol/l

32.8

32.7

0.00

(3023368) Bacteria identified in Blood by Culture

505

2651

2.34

49.56

4.8

4.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

12.71

47.91

3.1

2.0

umol/l

23.7

16.5

2.01

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

830

5588

2.05

40.94

11.3

9.2

mmol/l

1.2

0.34

715

4903

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

343

1646

2.39

40.24

2.1

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

774

5147

2.01

38.79

12.1

9.2

mmol/l

1.2

0.83

725

4781

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

548

3227

2.08

38.47

3.0

2.7

u/l

48.7

56.8

6.35

520

3016

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

802

5433

1.99

37.76

5.5

6.9

umol/l

13.0

14.1

0.43

749

5128

(3013826) Glucose [Moles/volume] in Serum or Plasma

934

6708

1.99

36.72

7.4

5.8

mmol/l

6.7

6.4

2.52

882

6251

(3024561) Albumin [Mass/volume] in Serum or Plasma

679

4400

1.97

35.77

5.2

6.3

g/l

35.4

36.7

7.12

632

4146

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

11.45

35.39

1.1

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1088

8366

2.02

33.67

7.2

7.1

u/l

97.7

89.6

1.76

1031

7896

(3019309) Folate [Moles/volume] in Red Blood Cells

290

1415

2.29

32.08

1.7

nmol/l

1169.1

1176.8

0.04

239

1102

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

255

1192

2.36

31.10

2.1

1.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

161

607

2.84

30.57

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

251

1182

2.34

30.03

2.1

1.9

—

(21494755) Public health laboratory ask at order entry panel

1530

0.12

28.24

1.4

1.3

—

(3032080) INR in Blood by Coagulation assay

562

3746

1.79

24.60

10.1

7.0

inr

1.2

0.61

175

1097

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1300

0.11

24.60

1.5

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

427

2620

1.87

24.52

4.2

mg/mmol

14.0

16.0

0.10

286

1733

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

5.47

24.06

3.6

2.5

umol/l

64.5

51.0

2.12

(3031040) Bacteria [#/volume] in Urine by Automated count

950

7373

1.75

24.03

6.7

3.9

e6/l

1923.8

1030.6

0.26

(1761868) Lipid panel - Serum or Plasma

245

4301

0.49

23.44

3.6

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

578

3957

1.74

22.59

3.9

4.0

u/l

31.9

33.1

0.24

554

3782

(3008152) Bicarbonate [Moles/volume] in Arterial blood

128

508

2.65

21.89

8.3

mmol/l

25.9

24.3

3.62

123

470

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

453

2916

1.78

21.81

3.0

2.3

u/l

348.6

272.0

0.60

432

2785

(3002032) Base excess in Venous blood by calculation

295

1663

1.95

21.61

6.6

8.2

mmol/l

1.9

1.4

1.42

243

1306

(3007853) Bacteria identified in Skin by Aerobe culture

272

1499

1.99

21.25

2.3

1.7

—

(3018418) pH of Serum or Plasma

449

2906

1.77

21.10

4.7

4.2

7.4

0.26

101

533

(3021447) Carbon dioxide [Partial pressure] in Venous blood

294

1669

1.94

21.05

6.6

8.2

kpa

5.9

5.8

1.62

282

1630

(3009508) Creatinine [Moles/volume] in Urine

500

3342

1.73

20.95

4.0

3.8

mmol/l

6.9

8.2

7.66

453

2918

(3026782) Osmolality of Urine

378

2336

1.82

20.71

3.9

2.9

mosm/kgh2o

534.1

568.5

1.65

328

2014

(3000850) Epithelial cells [#/volume] in Urine

392

2457

1.80

20.46

3.8

2.9

e6/l

9.3

5.7

3.58

349

2154

(3012516) Albumin [Mass/volume] in Urine

398

2511

1.79

20.29

3.5

3.4

mg/l

393.2

258.2

0.25

274

1683

(3014111) Lactate [Moles/volume] in Serum or Plasma

210

1073

2.11

20.12

9.1

10.7

mmol/l

1.4

1.3

0.49

193

1014

(3003396) Base excess in Arterial blood by calculation

205

1039

2.12

20.06

9.5

9.9

mmol/l

2.1

0.8

3.62

166

827

(3019550) Sodium [Moles/volume] in Serum or Plasma

1371

12155

2.16

19.94

23.3

13.8

mmol/l

139.4

139.6

2.42

1342

11843

(3035350) Ketones [Presence] in Urine by Test strip

749

5625

1.64

19.83

5.1

3.3

estimate

0.0

0.50

153

1028

(3015377) Calcium [Moles/volume] in Serum or Plasma

504

3421

1.70

19.72

2.6

3.3

mmol/l

2.4

0.26

450

3097

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

310

1830

1.87

19.57

1.8

1.6

pmol/l

43130218.6

18960487.9

0.35

262

1577

(3024354) Oxygen [Partial pressure] in Venous blood

270

1524

1.93

19.55

6.4

8.0

kpa

5.2

5.0

0.60

259

1487

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

536

3712

1.68

19.37

1.9

1.8

pmol/l

96.5

0.01

292

1962

(3023103) Potassium [Moles/volume] in Serum or Plasma

1371

12186

2.13

19.30

23.1

13.8

mmol/l

4.0

9.32

1339

11839

(3029937) Albumin [Presence] in Urine by Test strip

441

2913

1.72

18.93

5.8

3.6

estimate

0.0

1.08

155

1043

(3001019) Free T4 and TSH panel - Serum or Plasma

707

0.12

18.64

2.9

1.6

—

(3019060) Gas panel - Arterial blood

124

524

2.48

18.60

5.8

5.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

310

1869

1.82

18.16

8.4

9.5

mmol/l

1.2

0.17

296

1766

(3012095) Magnesium [Moles/volume] in Serum or Plasma

300

1793

1.83

18.07

5.0

7.3

mmol/l

0.8

0.06

282

1702

(3016502) Oxygen saturation in Arterial blood

183

923

2.11

18.07

10.2

10.7

94.5

95.8

1.33

176

889

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

259

1481

1.90

17.92

12.7

8.2

kpa

5.2

5.0

2.90

254

1413

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

571

4087

1.63

17.77

5.0

3.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

254

1450

1.90

17.65

12.8

8.3

mmol/l

1.8

1.1

2.36

199

1040

(3009343) pH of Capillary blood

257

1474

1.89

17.60

12.7

8.2

7.4

0.80

102

(42870588) Differential panel, method unspecified - Blood

631

4643

1.61

17.44

7.6

8.1

—

(3009261) Glucose [Presence] in Urine by Test strip

743

5686

1.59

17.37

5.1

3.4

estimate

0.0

0.80

151

1021

(3021601) Nitrite [Presence] in Urine by Test strip

737

5639

1.59

17.18

6.6

4.7

estimate

0.0

0.50

158

1072

(3002582) Erythrocytes [#/volume] in Urine

511

3586

1.63

17.07

5.0

3.7

e6/l

48.2

56.1

0.16

413

2771

(3006315) Basophils [#/volume] in Blood

842

6655

1.58

16.99

8.9

7.6

e9/l

0.0

0.24

751

5700

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

913

0.11

16.87

1.1

1.3

—

(1616796) Gas panel - Central venous blood

253

3.02

16.70

4.8

4.0

—

(3001604) Monocytes [#/volume] in Blood

839

6643

1.57

16.67

8.9

7.6

e9/l

0.6

3.37

747

5690

(3047181) Lactate [Moles/volume] in Blood

267

2.94

16.35

5.0

7.7

mmol/l

1.4

1.2

0.35

228

(3027801) Oxygen [Partial pressure] in Arterial blood

194

1036

2.00

16.34

9.7

9.9

kpa

11.5

13.1

4.18

188

993

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

194

1037

1.99

16.30

9.7

9.9

kpa

5.6

5.2

5.47

188

991

(3011397) Hemoglobin [Presence] in Urine by Test strip

405

2707

1.67

16.24

4.8

3.3

—

(3019150) Specific gravity of Urine by Refractometry

383

2525

1.69

16.17

5.6

3.5

kg/l

1.0

0.28

364

(3013115) Eosinophils [#/volume] in Blood

859

6878

1.56

15.94

10.2

8.1

e9/l

0.2

1.16

774

5996

(3000991) Gas panel - Venous blood

257

1521

1.83

15.82

11.0

10.6

—

(3012501) Base excess in Blood by calculation

220

3.09

15.57

5.7

5.0

mmol/l

2.8

2.2

0.67

139

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

354

2308

1.69

15.51

3.3

3.8

ng/l

1573.0

1178.7

0.37

294

1929

(3013650) Neutrophils [#/volume] in Blood by Automated count

915

7461

1.55

15.41

16.2

10.3

e9/l

4.2

3.9

4.88

823

6427

(3010421) pH of Blood

267

2.86

15.18

5.8

4.6

7.4

0.15

218

(3014576) Chloride [Moles/volume] in Serum or Plasma

222

1272

1.87

15.12

8.7

9.1

mmol/l

104.4

104.5

0.09

215

1248

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

170

893

2.01

14.96

6.1

6.4

ng/l

71.7

70.3

0.08

156

837

(3018095) Leukocytes [#/volume] in Urine

573

4234

1.56

14.93

5.8

4.2

e6/l

183.9

58.0

1.28

424

2952

(3023183) Ammonium ion [Moles/volume] in Plasma

337

2.61

14.56

2.2

3.7

umol/l

33.6

34.8

0.27

301

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

482

3439

1.58

14.56

3.9

3.1

ng/l

33.9

39.6

0.27

323

2077

(3019198) Lymphocytes [#/volume] in Blood

846

6844

1.52

14.29

9.2

7.5

e9/l

2.2

2.1

0.59

764

5993

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

629

4782

1.53

14.21

3.2

2.7

nmol/l

73.6

73.3

0.11

581

4433

(3027273) Bicarbonate [Moles/volume] in Venous blood

108

485

2.32

14.15

5.6

5.0

mmol/l

25.7

24.8

1.93

103

469

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

142

715

2.08

14.01

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

194

1105

1.86

13.39

14.2

9.1

kpa

9.3

9.6

1.27

189

1060

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

566

4252

1.52

13.28

5.5

3.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

948

7922

1.51

13.24

5.9

4.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1079

9289

1.54

12.90

4.7

3.7

pmol/l

14.5

14.6

0.20

1003

8563

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

138

715

2.02

12.59

2.7

4.0

ng/l

168.6

185.1

0.12

130

634

(3022313) Gas panel - Capillary blood

205

1216

1.79

12.37

12.6

8.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

313

2094

1.62

12.07

1.5

nmol/l

19.3

20.6

0.75

284

1802

(3009542) Hematocrit [Volume Fraction] of Blood

1122

12392

0.65

12.04

25.5

13.8

38.2

40.3

8.64

701

10178

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

284

1872

1.63

11.59

3.6

ng/l

294.8

641.7

1.79

191

1283

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

115

575

2.08

11.56

2.1

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

143

3.21

11.55

6.4

5.9

mmol/l

7.9

6.6

1.11

126

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

316

2.44

11.36

1.3

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

779

6371

1.45

11.34

9.8

7.9

8.3

8.5

0.58

750

6050

(36304419) Bacteria [Presence] in Urine

448

3291

1.51

11.32

5.0

3.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

136

728

1.95

11.31

4.5

4.6

mmol/l

1.2

0.29

123

643

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

107

526

2.11

11.25

10.9

13.6

—

(3006504) Eosinophils/100 leukocytes in Blood

773

6324

1.44

11.17

9.1

7.7

2.6

3.0

5.89

739

5979

(3018405) Lactate [Moles/volume] in Arterial blood

295

2.47

11.08

6.7

4.7

mmol/l

1.5

1.4

0.20

288

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1222

10938

1.56

11.08

5.7

4.3

mu/l

2.0

2.1

0.27

1135

10204

(3030467) Casts [#/volume] in Urine by Automated count

449

3312

1.50

11.08

5.1

3.5

e6/l

0.4

0.3

0.10

364

2504

(3022096) Basophils/100 leukocytes in Blood

753

6149

1.44

10.89

9.2

7.8

0.6

0.7

2.34

723

5835

(3019832) Treponema pallidum Ab [Presence] in Serum

1730

0.47

10.74

2.3

1.8

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.46

10.73

1.6

2.6

—

(40758558) Short blood count panel - Blood

472

3544

1.48

10.57

10.1

8.1

—

(3020891) Body temperature

366

2.28

10.50

8.5

5.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.05

10.39

3.9

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.05

10.39

3.9

3.0

—

(3000494) Fungus identified in Specimen by Culture

212

1349

1.66

9.85

1.5

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

344

2.27

9.82

1.9

2.0

ug/l

2.0

2.2

0.06

311

(40767503) Oxygen content in Capillary blood by calculation

221

2.59

9.76

3.2

2.9

16.9

17.0

0.15

137

(3022217) INR in Platelet poor plasma by Coagulation assay

162

962

1.76

9.69

16.0

17.9

inr

1.3

1.2

0.32

150

(3043409) Potassium [Moles/volume] in Arterial blood

242

2.49

9.50

6.4

4.6

mmol/l

3.9

0.05

223

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

140

2314

0.56

9.49

1.7

1.6

—

(3042936) Bacteria identified in Isolate by Culture

237

1565

1.61

9.48

2.3

2.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

8.62

9.34

6.2

8.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

191

1199

1.68

9.34

3.0

3.4

g/l

0.2

0.06

181

1135

(3027945) Reticulocytes/100 erythrocytes in Blood

205

1311

1.65

9.33

4.9

5.0

1.7

1.6

0.97

182

1217

(3013512) EKG study

352

2547

1.49

9.31

3.8

3.3

—

(3018010) Neutrophils/100 leukocytes in Blood

777

6492

1.39

9.28

9.0

7.4

54.6

53.6

1.13

740

6180

(3020191) Ethanol [Moles/volume] in Serum or Plasma

115

3.18

9.21

2.8

1.4

promille

1.4

0.01

(3002030) Lymphocytes/100 leukocytes in Blood

786

6597

1.39

9.05

9.3

7.6

30.7

31.4

0.88

753

6259

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

200

1286

1.64

8.90

6.8

8.7

mmol/l

24.0

23.7

0.75

191

1233

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

383

2846

1.46

8.79

2.3

2.6

mg/l

3.0

2.8

1.34

344

2504

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

234

1570

1.58

8.72

2.3

2.8

mmol/l

2.4

1.04

195

1373

(4198724)

130

2.97

8.67

2.8

2.0

—

(40768804) Tissue Pathology biopsy report

298

4056

0.67

8.63

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.83

8.51

3.9

4.2

umol/l

191.3

154.2

0.25

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

8.51

8.46

1.7

1.4

nmol/l

52.6

12.6

1.59

(3021901) Oxygen saturation in Capillary blood

235

2.39

8.15

3.0

5.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

794

0.34

8.07

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1605

0.53

7.86

2.2

2.6

ug/l

0.7

0.04

908

(3032641) Amino acids panel - Urine

6.23

7.71

1.0

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

151

939

1.67

7.64

5.4

4.9

0.8

0.9

0.06

276

(40761536) Microorganisms panel - Urine sediment

153

957

1.66

7.57

5.7

3.6

—

(40761535) Cells panel - Urine sediment

128

765

1.73

7.49

4.4

3.6

—

(3049233) Organic acids panel - Urine

4.63

7.40

1.3

—

(3021589) Normoblasts [#/volume] in Blood

716

6047

1.34

7.33

12.8

10.2

e9/l

0.0

0.28

593

4837

(3003181) Sodium [Moles/volume] in Urine

199

2.40

7.14

4.0

2.5

mmol/l

71.9

72.6

0.03

177

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

167

1088

1.60

7.02

7.2

5.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

151

960

1.63

7.01

4.3

2.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

337

2.03

6.72

1.8

1.3

—

(3000492) Spirometry study

1205

0.51

6.64

1.5

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

105

2.89

6.64

2.3

2.2

mmol/l

1.3

2.1

1.47

(3020779) Urea [Moles/volume] in Serum or Plasma

188

1279

1.53

6.54

10.2

11.7

mmol/l

7.5

7.0

0.60

183

1241

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

183

2.39

6.49

1.8

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

145

932

1.61

6.45

4.1

e9/l

72.9

67.8

0.93

107

665

(3018677) aPTT in Platelet poor plasma by Coagulation assay

251

1821

1.45

6.36

2.5

4.5

30.5

30.2

0.27

243

1779

(3047352) Trisomy 18 risk [Likelihood] in Fetus

334

0.24

6.26

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

160

2332

0.65

6.24

3.0

2.2

—

(3005033) Fetal Nuchal fold Thickness US

332

0.24

6.10

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

138

889

1.60

6.09

5.6

5.0

0.2

0.1

0.25

253

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

350

1.95

6.07

3.6

2.4

ug/l

429.4

309.5

0.62

329

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

343

0.26

5.90

1.4

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1366

12921

1.50

5.85

19.9

13.0

umol/l

68.7

71.4

1.55

1366

12916

(3052851) Hemolysis interference index of Serum or Plasma

363

1.91

5.80

3.0

3.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

339

0.26

5.76

1.3

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

309

1.98

5.68

1.6

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

309

1.98

5.68

1.6

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1361

12880

1.48

5.65

11.9

9.6

u/l

27.8

28.0

0.11

1324

12497

(3030905) Polymorphonuclear cells [#/volume] in Blood

255

2.07

5.63

3.6

3.8

e9/l

4.4

3.9

0.61

255

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

262

2.06

5.61

4.6

4.2

55.7

54.6

0.23

262

(3002179) Metamyelocytes/100 leukocytes in Blood

132

863

1.58

5.49

4.8

4.5

0.8

0.5

0.38

201

(3025159) Blasts/100 leukocytes in Blood

130

852

1.57

5.35

6.0

5.0

0.0

0.1

1.27

218

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

450

0.30

5.24

1.3

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1072

9811

1.30

5.23

7.3

4.8

mmol/mol

41.2

38.6

8.84

1001

9252

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

292

3712

0.74

5.21

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

416

0.28

5.17

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

415

0.28

5.15

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

415

0.28

5.15

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

414

0.28

5.13

1.3

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

184

1313

1.45

5.07

2.5

nmol/l

363.8

349.3

0.42

174

1246

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.65

4.98

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

384

3104

1.31

4.90

4.7

3.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

152

2138

0.68

4.90

2.8

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

949

10329

0.79

4.87

3.3

3.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

258

1969

1.37

4.84

4.4

3.3

e6/l

4.4

1.9

2.49

145

1104

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

380

0.28

4.74

1.2

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

217

1616

1.40

4.72

3.1

2.7

g/l

2.4

0.10

203

1519

(3010726) Horse dander IgE Ab [Units/volume] in Serum

554

0.41

4.71

1.2

u/ml

4.0

—

178

(3035637) Corticotropin [Mass/volume] in Plasma

295

1.89

4.68

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

620

0.44

4.66

1.3

1.2

u/ml

0.4

2.9

4.85

369

(3008401) Mugwort IgE Ab [Units/volume] in Serum

564

0.42

4.64

1.2

u/ml

0.2

1.2

3.10

356

(3022621) pH of Urine by Test strip

101

646

1.60

4.64

5.0

2.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.23

4.61

1.5

1.7

nmol/l

18.7

18.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.51

4.61

2.0

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1275

0.61

4.60

2.5

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

203

1502

1.40

4.58

3.3

2.8

21.2

23.3

1.68

170

1355

(3003888) Timothy IgE Ab [Units/volume] in Serum

585

0.43

4.51

1.2

u/ml

0.5

5.7

12.45

407

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

874

0.53

4.51

2.1

2.3

—

18.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

343

1.81

4.49

2.0

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

801

0.52

4.36

1.1

1.2

—

42.4

—

(3037121) Protein [Mass/volume] in Urine

530

1.64

4.34

4.6

6.3

g/l

0.3

0.07

331

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

377

1.75

4.33

2.0

1.9

—

(4034850)

311

1.83

4.30

9.7

9.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

230

1757

1.36

4.28

3.2

2.7

umol/l

12.5

14.0

2.61

213

1657

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

365

1.76

4.22

1.6

2.1

—

(3017732) Neutrophils [#/volume] in Blood

119

809

1.51

4.20

6.0

2.5

e9/l

4.5

4.1

0.55

100

687

(3033658) Prothrombin time (PT) actual/Normal

378

3107

1.29

4.18

4.8

5.9

90.5

90.4

0.03

367

3034

(3050129) First trimester maternal screen panel - Serum or Plasma

511

0.42

4.16

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

367

0.32

4.15

1.7

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

260

2034

1.33

4.13

4.3

3.1

e6/l

1.2

0.9

0.89

145

1163

(3003740) Influenza virus B Ag [Presence] in Specimen

366

0.32

4.13

1.7

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

476

1.65

4.08

2.3

—

(3044889) 12 lead EKG panel

807

7252

1.23

4.05

4.0

3.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.53

4.04

2.0

1.6

—

(3013931) Oligosaccharides [Presence] in Urine

10.03

4.01

1.1

1.0

—

(3008898) HLA-B27 [Presence]

581

0.47

3.95

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

366

1.72

3.91

1.6

2.2

—

(1002224) Polysomnography panel

549

0.46

3.86

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1120

10467

1.25

3.75

5.2

3.7

mmol/l

6.2

5.8

12.56

1029

9661

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

231

1.88

3.70

1.5

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.76

3.58

5.4

6.1

mmol/l

1.2

0.19

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

107

737

1.48

3.58

2.0

3.4

pmol/l

4.9

4.8

0.08

662

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

340

2814

1.27

3.50

1.8

1.7

mmol/l

1.6

1.4

2.00

293

2448

(3051611) Lipemic interference index of Serum or Plasma

145

2.09

3.48

2.7

4.8

—

(3028707) Methadone [Presence] in Urine by Screen method

450

1.60

3.45

3.5

3.0

—

(3008037) Lactate [Moles/volume] in Venous blood

187

1.95

3.44

3.4

3.7

mmol/l

1.5

0.06

182

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.77

3.42

1.3

1.7

nmol/l

1.6

1.1

0.40

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.73

3.34

14.4

3.8

mmol/l

5.7

7.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.45

3.33

2.1

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

8.59

3.26

2.8

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

619

1.50

3.25

1.9

1.6

mu/l

546.6

294.3

3.36

564

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.17

3.21

2.3

1.9

mg/l

0.5

1.5

—

(4094501)

251

0.35

3.18

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1308

12526

1.29

3.12

20.5

12.3

mg/l

26.1

22.7

3.11

1137

9363

(44790047)

245

1.77

3.12

1.4

2.1

—

(44806118)

245

1.77

3.12

1.4

2.1

—

(44790049)

245

1.77

3.12

1.4

2.1

—

(44790048)

245

1.77

3.12

1.4

2.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

298

1.70

3.11

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.46

3.04

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.90

3.02

2.1

3.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.55

2.95

1.4

4.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

250

1.74

2.93

1.6

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.10

2.88

1.4

1.2

—

(4024509)

2.44

2.87

2.0

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

301

0.39

2.82

1.5

—

(3008295) Osmolality of Serum or Plasma

165

1.89

2.81

2.0

1.4

mosm/kgh2o

296.1

288.2

0.63

120

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

143

1090

1.34

2.74

2.3

2.6

u/l

26.6

83.7

0.71

115

925

(3009214) Lutropin [Units/volume] in Serum or Plasma

668

1.43

2.73

2.5

1.8

u/l

7.4

7.0

0.14

484

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

174

1.85

2.73

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

5.01

2.72

3.6

2.5

u/field

0.6

0.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

5.01

2.72

15.0

3.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

0.48

2.67

1.2

1.1

u/ml

4.5

6.3

—

200

(46235355) HIV 1 and 2 tests - Meaningful Use set

259

3095

0.80

2.66

2.3

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.34

2.65

2.4

2.7

u/field

2.8

1.6

0.37

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

144

1105

1.33

2.64

3.0

5.4

u/l

245.1

260.9

0.43

138

1065

(3004809) Band form neutrophils/100 leukocytes in Blood

184

1.81

2.61

2.5

3.9

1.5

1.1

0.33

152

(3051651) Icteric interference index of Serum or Plasma

120

2.01

2.60

2.2

5.1

—

(3052592) Norovirus Ag [Presence] in Stool

4.01

2.56

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

341

0.46

2.53

1.1

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

146

1859

0.76

2.53

1.3

1.2

iu/ml

31.8

26.3

0.24

550

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

132

1704

0.75

2.53

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1037

0.69

2.53

2.3

1.9

—

(3002619) Bacteria identified in Specimen by Culture

3.04

2.52

1.0

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

298

2522

1.22

2.47

2.1

2.8

mg/l

1.4

1.3

0.27

241

1860

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

342

1.57

2.47

1.8

3.4

e6/l

353.8

763.6

0.45

266

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

342

1.57

2.47

1.7

3.4

e6/l

32.9

7.8

0.63

259

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.39

2.47

1.6

1.4

—

(3017509) Phencyclidine [Presence] in Urine

3.82

2.46

1.9

1.2

—

(3002256) Pathology report gross observation

1305

0.73

2.45

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.56

2.44

1.2

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

145

1.88

2.42

2.2

1.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

104

2.03

2.36

1.5

2.2

32.2

32.8

0.17

104

(3025941) Bacteria identified in Stool by Culture

697

1.39

2.34

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

357

0.50

2.34

1.2

1.1

u/ml

6.2

8.3

—

194

(3003338) MCHC [Mass/volume]

1118

11673

0.84

2.33

29.7

15.6

g/l

332.6

334.3

6.74

1110

11575

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

284

1.60

2.32

2.6

2.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

1.67

2.30

1.5

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

494

0.58

2.28

1.8

nmol/l

36.1

37.4

0.09

481

(3026389) Candida sp identified in Specimen by Organism specific culture

127

1.90

2.26

1.8

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

998

10505

0.86

2.24

4.1

3.5

mmol/l

1.4

1.3

6.37

914

9856

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

195

0.41

2.18

1.6

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

716

1.36

2.16

12.3

15.4

mg/l

1.1

1.2

0.76

694

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

189

1.71

2.14

1.6

1.4

u/l

13.6

19.8

0.93

163

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

142

1769

0.78

2.10

1.3

1.2

u/ml

5.5

10.1

0.93

697

(3044640) Blood type and Crossmatch panel - Blood

400

3532

1.18

2.08

2.8

2.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

205

0.44

2.08

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

2.06

0.0

2.5

—

188.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

1.75

2.06

1.5

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

334

1.51

2.05

1.5

1.6

—

(3019225) pH of Specimen

109

837

1.32

2.04

5.2

4.6

—

(3035285) Chloride [Moles/volume] in Venous blood

104

1.93

2.00

2.1

2.6

mmol/l

104.3

105.4

0.33

104

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

437

0.59

1.98

1.7

1.6

iu/ml

0.0

0.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

283

0.49

1.97

1.0

1.1

u/ml

1.7

4.5

—

113

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

213

1786

1.22

1.95

2.4

1.8

1.7

1.4

1.30

190

1615

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.36

1.94

1.3

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

106

1.90

2.1

2.6

mmol/l

4.1

4.0

0.30

106

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

174

1432

1.24

1.90

3.1

4.8

umol/l

8.8

7.5

0.12

136

1245

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

275

1.54

1.90

1.8

2.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

208

2456

0.82

1.89

2.0

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

1.88

0.0

1.4

—

(40768800) Prostate Pathology biopsy report

143

0.35

1.87

2.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

151

1.73

1.87

1.1

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

130

1.78

1.81

1.4

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

123

1.80

1.0

1.4

pmol/l

250.4

403.4

0.80

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.96

1.79

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

183

2176

0.82

1.79

3.5

19.9

21.2

0.46

854

(3023323) Follitropin [Units/volume] in Serum or Plasma

766

1.31

1.79

2.3

1.7

iu/l

14.9

19.7

0.96

586

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.17

1.77

4.2

9.2

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

349

1.45

1.70

1.4

2.4

nmol/l

0.9

0.7

1.20

303

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1047

10898

0.87

1.68

4.5

3.8

mmol/l

1.3

1.4

24.75

960

10241

(3000330) Specific gravity of Urine by Test strip

468

1.38

1.68

3.3

2.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

1.68

0.0

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

104

1.84

1.67

2.2

2.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

651

1.32

1.67

3.3

2.4

u/l

3334.6

3799.9

0.10

247

(3036489) Thrombin time

634

1.33

1.66

2.5

5.7

21.8

22.6

1.25

591

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

221

1.55

1.62

1.7

2.2

—

(3044290) Cell count panel - Cerebral spinal fluid

320

1.45

1.60

1.8

3.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

151

1.66

1.60

1.7

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

198

1.58

1.60

3.4

3.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

206

1.56

1.59

3.3

3.8

14.3

9.8

0.63

163

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

727

1.30

1.58

2.4

2.3

ug/l

5.6

8.3

0.87

643

(3033799) Differential panel - Peritoneal fluid

3.00

1.58

3.7

1.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.11

1.54

2.5

4.0

ug/l

128.7

135.7

0.05

(3043410) Blood group antigens tested for on Red Blood Cells

2.28

1.53

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

209

1.54

1.51

1.9

2.7

ug/min

17.7

104.2

2.53

128

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

193

1.56

1.51

7.6

4.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

317

1.43

1.49

4.6

12.3

u/ml

0.3

0.08

177

(3047007) Chlamydophila sp Ab [Presence] in Serum

330

0.60

1.48

1.1

1.2

—

(4035726)

875

0.75

1.47

1.4

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

315

2804

1.15

1.46

7.6

4.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

341

0.61

1.46

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.37

1.45

1.0

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.88

1.44

2.1

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.73

1.43

1.5

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

2.04

1.43

1.1

1.3

u/l

134.1

425.7

0.95

(3024928) Oxygen saturation in Venous blood

278

1.45

1.42

4.2

11.4

—

(3022145) Colonoscopy Study observation

1146

0.79

1.41

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

157

1.60

1.40

1.1

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

126

1.67

1.40

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

126

1.67

1.40

1.4

1.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

2.08

1.38

1.1

2.8

nmol/l

2.4

3.2

0.30

(1761482) Bacteria [#/volume] in Urine by Culture

214

1.50

1.38

3.9

3.4

—

(3017569) Oxygen content in Arterial blood

2.20

1.37

2.1

3.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

1.66

1.36

1.4

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

863

0.77

1.35

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.76

1.34

1.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.76

1.34

1.2

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.76

1.34

1.2

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

557

5171

1.12

1.33

4.8

4.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

579

0.72

1.33

1.1

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

896

8549

1.11

1.28

4.3

4.1

mm/h

11.8

9.7

4.73

835

7987

(3038177) Helicobacter pylori Ab [Presence] in Serum

217

0.55

1.27

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1156

11193

1.13

1.25

26.9

15.6

13.8

13.4

12.59

1130

10978

(3014599) Egg white IgE Ab [Units/volume] in Serum

237

0.59

1.19

1.1

1.4

u/ml

1.0

5.5

—

148

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

566

0.73

1.18

1.1

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

1.2

—

(40761511) CBC panel - Blood by Automated count

1329

13002

1.15

1.16

19.3

10.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

257

1.41

1.15

2.0

3.3

mu/l

18.8

21.1

0.22

246

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.50

1.15

1.0

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

155

0.51

1.13

2.8

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

294

1.37

1.10

2.5

2.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.38

1.09

1.2

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

128

1.57

1.08

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

129

1.56

1.05

1.5

—

(3011412) CD3 cells [#/volume] in Blood

230

1.40

1.01

3.8

3.7

e9/l

1.3

1.5

0.31

151

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

846

8106

1.09

1.01

4.3

3.5

u/l

49.8

43.0

0.96

786

7719

(3004588) Protein electrophoresis panel - Serum or Plasma

494

1.26

0.99

1.4

2.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1147

0.83

0.97

1.7

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

135

1167

1.17

0.97

3.1

3.4

g/l

9.8

0.01

121

1096

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.80

0.96

1.8

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.22

0.93

1.3

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.73

0.92

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

1.82

0.92

1.3

1.2

nmol/l

161.6

148.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

110

1.55

0.90

1.2

1.0

—

(3037756) Immunofixation for Serum or Plasma

143

1.47

0.89

1.3

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

168

1.43

0.89

3.0

4.2

e6/l

328.3

358.1

0.11

114

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

345

0.72

0.87

1.9

3.4

u/ml

55.9

4156.1

0.78

289

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.00

0.87

1.0

1.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.82

0.85

7.4

9.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1142

0.85

2.7

2.3

nmol/l

9.8

13.1

3.22

997

(3037522) Nuclear Ab [Titer] in Serum

150

1691

0.87

0.84

1.4

titre

653.9

520.1

0.39

314

(21494814) CD8 cells/100 lymphocytes in Specimen

1.78

0.84

3.9

2.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.74

0.82

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.74

0.82

1.3

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.88

0.81

4.3

3.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.70

0.80

1.1

—

73.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.70

0.80

1.1

—

87.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1071

10967

0.92

0.80

4.6

3.9

mmol/l

4.4

4.7

20.63

993

10348

(3027944) Amphetamines [Presence] in Urine

985

0.84

0.79

3.1

2.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.79

0.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.79

0.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.79

0.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.79

0.0

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

148

0.61

0.79

1.2

1.3

—

250.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.82

0.79

1.5

2.3

—

(40768793) Breast Pathology biopsy report

199

0.65

0.79

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

301

2781

1.10

0.78

2.7

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.53

0.78

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

121

0.58

0.78

2.0

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

199

1.36

0.78

1.2

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.77

0.76

2.7

2.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

527

5538

0.92

0.76

3.5

3.0

ug/l

99.6

100.0

0.02

489

5199

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.67

0.74

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.67

0.74

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

487

1.22

0.74

2.3

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

622

0.81

0.74

2.2

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

116

1.47

0.74

1.2

1.3

nmol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

134

0.59

0.73

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

1.48

0.73

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

100

1.50

0.72

1.7

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.58

0.71

9.3

9.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.92

0.70

1.2

—

(3042733) HLA Ab [Presence] in Serum

1.53

0.68

3.8

4.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.67

0.68

3.0

2.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.60

0.68

1.4

1.3

g/l

40.8

31.7

1.75

(3028300) Cannabinoids [Presence] in Urine

1000

0.86

0.67

3.2

2.2

—

(3023410) Appearance of Cerebral spinal fluid

214

1.31

0.66

1.7

4.7

—

(3027008) Opiates [Presence] in Urine

997

0.86

0.65

3.2

2.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1045

10198

1.07

0.65

16.1

10.2

ml/min/173m2

96.0

90.1

9.54

811

8053

(3017704) Immunofixation for Urine

1.59

0.65

1.3

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

233

1.29

0.64

1.7

1.5

nmol/l

0.3

0.16

184

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.72

0.64

1.0

1.2

—

(4010399)

766

1.16

0.63

1.4

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

181

1.33

0.63

1.5

3.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

424

0.80

0.62

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

103

0.58

0.62

1.3

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.63

0.62

1.1

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.63

0.62

1.1

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.63

0.62

1.1

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.63

0.62

1.1

1.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

233

0.73

0.61

4.2

3.7

u/ml

23.5

26.6

0.05

219

(3028026) IgM [Mass/volume] in Serum or Plasma

105

929

1.14

0.61

1.9

g/l

1.2

0.00

877

(3025130) Human papilloma virus identified in Specimen

137

0.65

0.60

1.4

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

990

0.87

0.60

3.2

2.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.60

0.0

9.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

2.4

—

42.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.60

0.0

2.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.54

0.59

7.0

7.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.54

0.59

5.8

7.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

386

0.80

0.57

1.1

—

9.7

—

(3014271) Vancomycin [Susceptibility]

1.72

0.57

7.5

2.2

—

(3016879) Cocaine [Presence] in Urine

933

0.87

0.57

3.3

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

202

1.29

0.57

3.7

3.8

e9/l

0.5

0.2

0.67

158

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

132

1.37

0.57

1.2

1.3

nmol/l

0.6

0.18

126

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.67

0.56

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.56

1.0

1.2

—

(4281824)

1.51

0.56

2.1

1.2

—

(3035880) pH of Pleural fluid

1.62

0.55

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

124

1.37

0.55

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.47

0.54

5.8

2.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

806

1.14

0.54

2.8

2.6

ml/min/173m2

78.8

72.6

0.48

293

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

204

1.28

0.54

3.7

e6/l

490.2

588.4

0.46

158

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

294

0.78

0.53

1.4

1.2

u/ml

1.9

9.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.48

0.53

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

240

1.25

0.53

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

108

1.39

0.53

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.43

0.52

6.2

3.9

umol/l

81.7

120.9

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.52

0.52

3.0

2.7

ug/g

219.6

149.0

—

(3023419) Bacteria identified in Sputum by Culture

117

1.37

0.52

2.1

4.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

1.40

0.51

1.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

781

1.13

0.51

2.4

4.4

ug/l

111.2

16.8

0.51

619

(3036782) Glucose [Moles/volume] in Pleural fluid

1.41

0.51

1.6

1.2

mmol/l

5.6

6.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

357

0.81

0.50

1.3

1.4

—

(36660697) Celiac disease serology panel - Serum

137

1496

0.91

0.50

1.3

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

162

1.30

0.49

1.2

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

101

1120

0.89

0.49

1.6

1.4

u/ml

216.0

268.7

0.24

1043

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

290

0.79

0.49

1.4

1.2

u/ml

3.6

2.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

110

1.37

0.48

2.5

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

259

2746

0.93

0.48

3.3

3.9

ug/l

1.5

2.0

2.04

232

2497

(3024263) Appearance of Synovial fluid

1.49

0.47

1.4

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.49

0.47

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

154

0.71

0.47

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.46

0.46

2.0

1.4

—

11.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

142

0.70

0.46

1.8

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.60

0.45

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

164

0.73

0.45

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.59

0.45

1.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.40

0.44

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.40

0.44

1.2

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.45

0.44

3.1

3.0

u/ml

526.8

1020.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

166

1.27

0.43

1.5

3.7

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

435

0.85

0.42

1.5

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.42

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.66

0.42

1.3

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.65

0.42

2.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

194

1.24

0.41

1.7

4.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

1424

14321

0.91

0.41

32.7

17.9

g/l

134.5

137.0

8.08

1405

14144

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.36

0.41

2.1

1.7

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

4.0

—

4.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.47

0.40

1.2

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.47

0.40

1.2

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

132

1.29

0.40

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.0

—

(3045788) Cell count panel - Pleural fluid

1.31

0.39

1.5

1.4

—

(3022670) pH of Venous cord blood

1.43

0.39

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.43

0.39

1.2

2.0

—

(3026361) Erythrocytes [#/volume] in Blood

1424

14316

0.92

0.38

32.2

17.8

e12/l

4.6

3.19

1382

13864

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

151

1.26

0.38

1.3

1.5

—

(3035941) MCH [Entitic mass]

1424

14315

0.92

0.37

32.1

17.7

29.7

29.9

1.88

1405

14141

(3014765) Yersinia sp identified in Stool by Organism specific culture

397

0.85

0.37

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.32

0.37

1.4

1.1

—

43.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

807

0.90

0.37

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.35

0.37

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1092

11060

0.95

0.37

5.0

4.1

mmol/l

2.6

2.8

13.11

1005

10358

(3010813) Leukocytes [#/volume] in Blood

1425

14323

0.92

0.37

32.4

17.8

e9/l

7.2

6.7

8.30

1384

13871

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

396

0.85

0.36

1.2

—

(3024731) MCV [Entitic volume]

1424

14313

0.92

0.36

32.1

17.7

89.2

89.1

0.33

1405

14138

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

157

0.76

0.36

2.2

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

201

0.79

0.36

1.3

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.33

0.35

1.0

1.1

—

(3007461) Platelets [#/volume] in Blood

1423

14301

0.92

0.35

32.3

17.8

e9/l

255.2

257.9

0.76

1385

13887

(3027231) Wheat IgE Ab [Units/volume] in Serum

124

0.72

0.35

1.0

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

510

0.88

0.34

1.6

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

242

2537

0.94

0.34

2.6

3.2

umol/l

2829.5

4958.4

0.54

209

2275

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.37

0.34

1.1

ratio

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

362

3753

0.95

0.34

1.4

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

119

1105

1.08

0.33

4.1

3.9

30.6

31.2

0.24

773

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

199

0.80

0.33

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

387

3732

1.05

0.33

1.5

u/ml

2.9

2.3

0.20

855

(42529406) Shigella sp [Presence] in Stool by Culture

402

0.87

0.33

1.3

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

165

0.79

0.32

1.0

1.3

u/ml

1.3

21.9

—

132

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

436

1.13

0.32

1.9

2.0

—

(3006598) pH of Arterial cord blood

183

1.20

0.31

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

248

1.17

0.31

2.6

1.8

—

(3045424) Erythrocytes [Presence] in Urine

193

1.19

0.30

2.3

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

419

1.12

0.30

2.0

u/ml

78.5

101.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.27

0.30

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.27

0.30

1.3

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.29

0.28

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.29

0.28

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.67

0.26

1.0

2.9

—

37684.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

190

1814

1.05

0.26

2.1

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.18

0.24

1.3

1.4

—

69.6

—

(3011648) Oxygen content in Venous blood

142

1.20

0.24

6.6

18.9

12.3

11.6

0.71

142

(3000570) Elastase.pancreatic [Mass/mass] in Stool

359

1.12

0.24

1.3

1.5

ug/g

305.8

325.9

0.26

209

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.74

0.24

1.0

g/l

164.0

161.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.72

0.24

1.2

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.71

0.24

1.0

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

147

0.81

0.23

1.1

1.3

u/ml

4.3

16.2

—

123

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

211

0.85

0.23

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.28

0.23

1.6

3.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

514

0.91

0.22

1.7

1.8

u/ml

250.5

213.3

0.42

264

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

157

0.83

0.22

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

524

0.91

0.22

1.7

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.76

0.22

1.3

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

210

1.14

0.21

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

156

0.83

0.21

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

3.5

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

334

1.11

0.21

1.4

1.2

—

(4268621)

135

1.19

0.21

2.6

2.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

177

0.85

0.21

1.6

2.0

—

1340.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

333

3415

0.97

0.20

1.6

g/l

1.9

2.0

0.90

190

1970

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

3.7

—

0.5

—

(3045716) Anion gap in Serum or Plasma

1.25

0.20

2.5

2.0

mmol/l

9.3

9.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

155

1.16

0.19

2.3

1.9

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.15

0.19

1.2

1.1

—

14.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

118

1.19

0.19

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

196

0.86

0.19

1.2

1.3

—

(4146454)

1.23

0.18

3.4

2.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.21

0.18

1.3

2.2

—

(40768446) Kidney Pathology biopsy report

100

1.20

0.18

2.9

2.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

1.20

0.18

1.7

3.8

60.4

54.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.11

0.17

1.0

1.3

—

(3012441) Differential panel - Pleural fluid

0.71

0.16

1.8

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.71

0.16

1.0

2.4

—

(3028433) Virus identified in Specimen by Culture

1.13

0.16

1.1

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

193

0.88

0.16

1.2

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

151

0.86

0.16

2.6

2.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

206

1.12

0.15

1.8

1.5

—

(3042631) Mycobacterium sp identified in Specimen

111

1.17

0.15

2.6

3.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

341

1.09

0.15

2.3

1.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.15

0.15

1.4

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

216

1.11

0.15

1.2

1.3

u/ml

1.7

5.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

197

1.12

0.15

1.5

2.2

g/l

0.0

0.00

184

(3013139) Helicobacter pylori Ag [Presence] in Stool

727

0.95

0.15

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

481

0.93

0.15

2.1

1.8

—

(4306422)

198

1.11

0.14

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

127

1226

1.04

0.13

1.7

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1.11

0.13

1.5

2.2

g/l

0.0

0.00

185

(40759836) Histone Ab [Presence] in Serum by Immunoblot

107

0.84

0.13

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

107

0.84

0.13

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

107

0.84

0.13

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

108

0.83

0.13

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

108

0.83

0.13

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

108

0.83

0.13

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

113

1.15

0.13

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

240

0.91

0.11

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

230

1.09

0.11

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

464

1.06

0.11

2.1

u/l

44.8

40.3

0.73

427

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

201

1.09

0.11

1.0

1.1

114.0

111.6

0.12

185

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

208

0.91

0.10

2.4

2.6

—

(40768797) Stomach Pathology biopsy report

143

1393

1.03

0.10

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

238

0.92

0.10

1.7

1.4

—

(3000012) Reticulocyte production index

1.11

0.09

1.0

1.8

—

(4211845)

1.06

0.09

3.0

2.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

203

1.08

0.09

1.3

1.5

—

(3044941) Cell count panel - Synovial fluid

155

1.10

0.09

1.9

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

126

1.11

0.08

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

359

0.94

0.08

1.5

1.9

—

(3048689) Calprotectin [Mass/mass] in Stool

201

1972

1.02

0.08

2.1

2.9

ug/g

268.4

114.4

0.70

158

1615

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.83

0.08

1.0

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.83

0.08

1.0

1.1

—

394.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.80

0.08

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

214

1.07

0.08

1.7

2.2

g/l

0.0

0.50

200

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

154

0.91

0.08

1.0

1.1

91.8

94.1

0.12

146

(3029075) Extractable nuclear Ab panel - Serum

0.78

0.08

1.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1.06

0.08

1.7

2.0

g/l

3.6

3.8

0.24

202

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1.06

0.08

1.7

2.0

g/l

7.4

7.3

0.09

212

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1.06

0.08

1.7

2.0

—

(40768441) Liver Pathology biopsy report

117

1.11

0.08

1.3

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1.14

0.08

1.6

1.3

e6/l

11200.6

17537.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.06

0.08

1.0

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.82

0.07

1.2

1.1

iu/ml

234.7

206.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.82

0.07

4.7

5.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.87

0.07

2.4

2.8

ug/l

23.1

125.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.87

0.07

1.3

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.86

0.07

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.86

0.07

4.1

4.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

101

0.89

0.06

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

967

1.02

0.06

1.2

iu/ml

40.9

147.7

7.02

362

(4027681)

111

0.90

0.06

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

577

0.97

0.06

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

483

1.04

0.06

2.5

u/ml

39.6

43.0

0.08

464

(4062490)

178

1.07

0.05

1.6

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

283

0.95

0.05

1.3

1.1

iu/ml

300.5

163.6

—

(3004616) Nuclear Ab [Presence] in Serum

110

0.91

0.05

1.6

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1.05

0.05

1.5

2.1

g/l

38.7

38.6

0.03

193

(21494434) Karyotype in Bone marrow

120

1.08

0.04

1.4

1.3

—

(3011288) Drugs identified in Urine by Screen method

664

1.02

0.04

5.9

3.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

209

1.05

0.04

1.2

1.3

u/ml

4.9

5.0

0.02

(3024891) Influenza virus A+B Ag [Presence] in Specimen

526

1.03

0.04

1.6

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

437

1.03

0.04

1.1

u/ml

3.6

9.7

—

(44813793)

141

1.06

0.03

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

280

1.04

0.03

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

280

1.04

0.03

1.9

2.4

—

(3021788) Differential panel - Synovial fluid

167

0.96

0.01

1.9

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

103

1021

1.01

0.01

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

783

1.01

0.00

3.2

2.3

—

(3024932) HLA-DR beta [Type]

1.04

0.00

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

100

1.00

0.00

1.2

1.3

—

(40768443) Skin Pathology biopsy report

394

0.99

0.00

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

125

1.04

0.00

1.2

1.1

mg/l

218.8

241.6

0.28

109

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

315

1.02

0.00

1.6

1.9

iu/l

5.5

5.1

0.05

115

(3000093) Morphology [Interpretation] in Blood Narrative

123

0.97

0.00

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

200

1.00

0.00

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

101

0.99

0.00

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

253

0.99

0.00

1.0

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

236

1.02

0.00

1.8

2.3

g/l

0.8

0.02

214

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

358

1.00

0.00

7.3

9.4

iu/ml

195.3

369.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

109

1.01

0.00

1.1

1.0

—

(3024471) HLA-A [Type]

1.03

0.00

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

5.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.0

—

27.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

3.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.90

0.00

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

1.00

0.00

1.3

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.02

0.00

1.4

1.2

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

2.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.95

0.00

1.0

1.3

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

11.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

2.0

—

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.2

—

8.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.88

0.00

2.0

1.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.94

0.00

4.4

3.8

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.3

—

3.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.94

0.00

4.4

3.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

10.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

829.4

—

(3013762) Body weight Measured

0.00

0.0

1.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

3.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.00

0.00

1.2

1.1

miu/ml

2252.3

1490.6

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

8.7

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1599.8

—

(40768806) Pleura Pathology biopsy report

0.95

0.00

2.2

1.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_MENTALRET – Mental retardation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mental retardation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Mental retardation (KRA_PSY_MENTALRET)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints